Antioxidant properties of calcium antagonists related to membrane biophysical interactions
- PMID: 10480441
- DOI: 10.1016/s0002-9149(99)00360-4
Antioxidant properties of calcium antagonists related to membrane biophysical interactions
Abstract
The antioxidant activities of representative calcium antagonists, including amlodipine, verapamil, and diltiazem, were measured in hepatic microsomal membranes by the Fe-catalyzed, hydroxyl radical-producing system (dihydroxyfumarate + Fe3+) and assessed by malondialdehyde (MDA) formation. Despite the absence of L-type calcium channels in this membrane preparation, the calcium antagonists showed dose-dependent antioxidant activity. The biophysical mechanism for calcium-antagonist antioxidant activity was evaluated using radioligand binding assays, high-resolution differential scanning calorimetry, and small-angle x-ray diffraction approaches. These analyses demonstrated that calcium-antagonist antioxidant potency correlated directly with the compounds' relative affinity for the membrane lipid bilayer and ability to modulate membrane thermodynamic properties (amlodipine >> verapamil > diltiazem). The charged 1,4-dihydropyridine calcium antagonist, amlodipine, had the highest affinity for the membrane lipid bilayer (Kp>10(4)) and produced the largest changes in membrane thermodynamic properties, including a reduction in thermal phase transition temperature (-11%), enthalpy (-14%), and cooperative unit size (-59%), relative to control phosphatidylcholine liposomes. Electron density profiles generated from x-ray diffraction data demonstrated that amlodipine effected a broad and dose-dependent increase in molecular volume associated with the membrane hydrocarbon core. These data indicate that lipophilic calcium antagonists inhibit lipid peroxidation in cellular membranes as a result of modulating physicochemical properties of the membrane lipid bilayer, independently of calcium channel inhibition. Amlodipine had the most potent antioxidant activity as a result of distinct biophysical interactions with the membrane lipid bilayer. The nonreceptor-mediated antioxidant activity of calcium antagonists may contribute to cytoprotective mechanisms of action in cardiovascular diseases.
Similar articles
-
[Membrane biophysical interaction of amlodipine and antioxidant properties].Drugs. 2000;59 Spec No 2:9-16. Drugs. 2000. PMID: 11002854 French.
-
Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine.J Mol Cell Cardiol. 1999 Jan;31(1):275-81. doi: 10.1006/jmcc.1998.0867. J Mol Cell Cardiol. 1999. PMID: 10072734
-
Antioxidant and cytoprotective activities of the calcium channel blocker mibefradil.Biochem Pharmacol. 1998 Jun 1;55(11):1843-52. doi: 10.1016/s0006-2952(98)00070-7. Biochem Pharmacol. 1998. PMID: 9714303
-
Cholesterol, calcium and atherosclerosis: is there a role for calcium channel blockers in atheroprotection?Int J Cardiol. 1997 Dec 31;62 Suppl 2:S55-66. doi: 10.1016/s0167-5273(97)00242-8. Int J Cardiol. 1997. PMID: 9488196 Review.
-
Lercanidipine: short plasma half-life, long duration of action and high cholesterol tolerance. Updated molecular model to rationalize its pharmacokinetic properties.Blood Press Suppl. 1998;2:10-7. Blood Press Suppl. 1998. PMID: 9850437 Review.
Cited by
-
Quantitative Estimation of the Hydrogen-Atom-Donating Ability of 4-Substituted Hantzsch Ester Radical Cations.ACS Omega. 2021 Sep 2;6(36):23621-23629. doi: 10.1021/acsomega.1c03872. eCollection 2021 Sep 14. ACS Omega. 2021. PMID: 34549160 Free PMC article.
-
Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats.Mol Cell Biochem. 2004 Apr;259(1-2):91-9. doi: 10.1023/b:mcbi.0000021360.89867.64. Mol Cell Biochem. 2004. PMID: 15124912
-
The macrolide antibiotic azithromycin interacts with lipids and affects membrane organization and fluidity: studies on Langmuir-Blodgett monolayers, liposomes and J774 macrophages.J Membr Biol. 2003 Apr 1;192(3):203-15. doi: 10.1007/s00232-002-1076-7. J Membr Biol. 2003. PMID: 12820665
-
Formulations of Amlodipine: A Review.J Pharm (Cairo). 2016;2016:8961621. doi: 10.1155/2016/8961621. Epub 2016 Oct 16. J Pharm (Cairo). 2016. PMID: 27822402 Free PMC article. Review.
-
Antioxidant activity of amiodarone on human lipoprotein oxidation.Br J Pharmacol. 2001 Jul;133(5):739-45. doi: 10.1038/sj.bjp.0704126. Br J Pharmacol. 2001. PMID: 11429399 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical